Moxifloxacin Eye Drops Manufacturer in India

Moxifloxacin is a fourth-generation fluoroquinolone with broader antibacterial spectrum than Ciprofloxacin (second-generation). Key advantages include: significantly better gram-positive coverage (including Streptococcus pneumoniae and Staphylococcus aureus), activity against atypical organisms, superior corneal penetration achieving higher intraocular concentrations, preserved activity against many Ciprofloxacin-resistant strains, and a preservative-free formulation that improves ocular tolerability.

Yes. The standard Moxifloxacin 0.5% ophthalmic solution is formulated without preservatives — a significant advantage over benzalkonium chloride-preserved alternatives. Preservative-free ophthalmic antibiotics reduce epithelial toxicity, are better tolerated in patients with pre-existing ocular surface disease, and are preferred for peri-operative use where repeated dosing is required without compromising the corneal epithelium.

Moxifloxacin 0.5% eye drops are used for bacterial conjunctivitis (pink eye), bacterial keratitis (corneal ulcer), blepharitis with conjunctival involvement, pre-operative and post-operative antibiotic prophylaxis in cataract and other intraocular surgeries, and dacryocystitis. Its broad-spectrum activity makes it the preferred first-line antibiotic eye drop in most hospital ophthalmology settings globally.

Yes. Moxifloxacin eye drops are widely used as peri-operative antibiotic prophylaxis for cataract surgery — one of the highest-volume surgical procedures globally. 9M India manufactures Moxifloxacin in 5ml and 10ml sterile bottles suitable for institutional surgical supply. Large-volume orders with institutional packaging and complete GMP documentation are available for hospital and government procurement.

Moxifloxacin 0.5% eye drops are available in 5ml and 10ml sterile multi-dose bottles. Institutional bulk packaging for hospital and government programme supply can be arranged. Custom private label packaging with multilingual labelling for export markets is also available. Please contact our export team for specific packaging and labelling requirements.

Documentation available includes WHO-GMP Certificate, DCGI Manufacturing Licence, Certificate of Pharmaceutical Product (CoPP), batch-wise Certificate of Analysis (sterility, particulate matter, pH, assay, preservative content), ICH Zone IVb stability data and CTD/ACTD dossiers on request. Moxifloxacin eye drops are exported to 15+ countries across the Middle East, CIS, Africa and ASEAN.

Yes. 9M India manufactures Moxifloxacin + Prednisolone Acetate combination eye drops — combining the broad-spectrum antibiotic with a corticosteroid for conditions requiring simultaneous anti-infective and anti-inflammatory treatment. This combination is widely used post-operatively after cataract surgery and in bacterial keratitis with significant inflammatory component.